Research & Development

The Research & Development team at Scribe Therapeutics is dedicated to advancing the engineering and application of CRISPR technologies to address genetic disorders. This multidisciplinary team conducts cutting-edge research, develops innovative CRISPR molecules, and collaborates on therapeutic discovery and formulation, ensuring the translation of scientific breakthroughs into effective treatments. Their work encompasses areas such as CNS biology, liver therapeutics, analytical chemistry, and computational biology, driving the next generation of genetic medicine.